1. Leukemia Program, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH;
2. Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada;
3. Leukemia Division, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
4. Institute of Medical Sciences, Department of Medicine, University of Toronto, Toronto, ON, Canada;
5. Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL;
6. Odette Cancer Centre, Division of Medical Oncology and Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada;
7. Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH;
8. Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY;
9. Department of Medicine, School of Medicine, Duke University, Durham, NC;
10. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;
11. Division of Hematology, Mayo Clinic, Rochester, MN;
12. Grand River Regional Cancer Centre, Kitchener, ON, Canada;
13. Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI;
14. Division of Hematology/Oncology, Department of Medicine, University of Rochester, Rochester, NY;
15. Department of Internal Medicine, University of Toronto, Toronto, ON, Canada;
16. Health Science Center, Department of Clinical Medicine, Universidad de Guadalajara, Guadalajara, Mexico; and
17. The Center of Gerontology and Geriatrics/National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China